Living With HIV : The Lazarus Effect - by Liz Highleyman

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
POZ Focus

Back to home » HIV 101 » POZ Focus » Living With HIV

Table of Contents


September 23, 2008

Living With HIV

Going the Distance

Look How Far We’ve Come

Beating the Odds

Staying a Step Ahead

The Lazarus Effect

 
What You're Talking About
Let's Kick ASS - AIDS Survivor Syndrome (36 comments)

Why I Still (Kinda, Sorta) Go to the Gym (blog) (16 comments)

FDA Approves Gilead’s Hep C Drug Harvoni (via Hep) (9 comments)

Ebola vs. AIDS, Obama vs. Reagan (blog) (8 comments)

Health Care is a Human Right (8 comments)

90 Years Old and HIV Positive (7 comments)
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


emailprint

The Lazarus Effect

by Liz Highleyman

When John Iversen, now 59, tested HIV positive in January 1986, he threw himself into AIDS activism, co-founding ACT UP/East Bay and a Berkeley needle exchange program. By the late 1980s, his CD4s had fallen to about 200. Observing that AZT (retrovir) taken by itself didn’t seem to help people, he joined a trial of Compound Q, an experimental herbal therapy. His CD4 count climbed, but he developed rheumatoid arthritis that left him bedridden and he experienced severe bowel problems caused by cytomegalovirus (CMV) infection.  

With a CD4 count of 46 in 1995, Iversen started a drug regimen of three NRTIs and a year later added a double dose of a PI. He gained 50 pounds, stopped his CMV treatment and could finally get around without a walker.

After a decade on the same PI, Iversen has had difficulty keeping his viral load consistently undetectable with his current drug combo. He hopes that a switch to Prezista (darunavir) plus Truvada plus the new NNRTI Intelence (etravirine) will do the trick. He’s had “no major side effects” on his current regimen, which he attributes to complementary therapy including vitamins, Chinese herbs and acupuncture. He also watches what he eats, does yoga and exercises regularly.

Though still on disability, Iversen works tirelessly as an advocate. He helps people with HIV in developing countries gain access to the treatments that turned his own life around, and he raises several thousand dollars a year for an orphanage started by HIV-positive people in Uganda.



Search: John Iversen, ACT UP/East Bay, needle exchange program, Berkeley, trial, Compound Q


Scroll down to comment on this story.




Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[ Go to top ]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.